Edition:
India

EyeGate Pharmaceuticals Inc (EYEG.OQ)

EYEG.OQ on NASDAQ Stock Exchange Capital Market

1.27USD
15 Dec 2017
Change (% chg)

$0.07 (+5.83%)
Prev Close
$1.20
Open
$1.20
Day's High
$1.29
Day's Low
$1.20
Volume
49,578
Avg. Vol
28,758
52-wk High
$3.89
52-wk Low
$0.90

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.07 -0.241
Jun '17 0.15 -0.276
Mar '17 0.18 -0.279
FY 2016 Dec '16 0.16 -0.376
Sep '16 0.27 -0.364
Jun '16 0.23 -0.457
Mar '16 0.00 -0.311
FY 2015 Dec '15 0.00 -0.351
Sep '15 0.00 -0.189
Jun '15 0.00 -0.242
Mar '15 0.00 -3.227
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Dec-17 1 0.41 0.41 0.41 6.93
Earnings (per share)
Quarter Ending Dec-17 1 -0.24 -0.24 -0.24 -0.12
Quarter Ending Mar-18 1 -0.20 -0.20 -0.20 --
Year Ending Dec-17 1 -1.02 -1.02 -1.02 -0.88
Year Ending Dec-18 1 -0.66 -0.66 -0.66 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.14 32.93
P/E High - Last 5 Yrs. -- 40.91 45.62
P/E Low - Last 5 Yrs. -- 23.80 24.34
Beta -- 0.90 0.88
Price to Sales (TTM) 27.35 3.93 5.40
Price to Book (MRQ) 4.59 4.81 5.38
Price to Tangible Book (MRQ) -- 5.53 6.78
Price to Cash Flow (TTM) -- 23.04 23.45
% Owned Institutions 39.45 0.88 1.40

Dividends

  Company industry sector
Dividend Yield -- 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.52
Dividend 5 Year Growth Rate -- 4.33 5.17
Payout Ratio(TTM) -- 45.73 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -36.79 3.57 9.00
Sales (TTM) vs TTM 1 Yr. Ago 227.14 4.66 5.38
Sales - 5 Yr. Growth Rate -- 10.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 39.61 16.54 19.67
EPS (TTM) vs TTM 1 Yr. Ago 0.93 -- --
EPS - 5 Yr. Growth Rate -- 9.86 10.79
Capital Spending - 5 Yr. Growth Rate -- 15.30 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) 1.13 2.88 2.98
LT Debt to Equity (MRQ) 0.21 9.47 11.56
Total Debt to Equity (MRQ) 0.21 13.43 15.81
Interest Coverage (TTM) -963.38 36.29 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.14 54.83
Gross Margin - 5 Yr. Avg. -- 52.29 52.40
EBITD Margin (TTM) -1,734.30 -- --
EBITD - 5 Yr. Avg -- 18.46 15.24
Operating Margin (TTM) -1,736.12 14.50 7.76
Operating Margin - 5 Yr. Avg. -- 14.42 10.75
Pre-Tax Margin (TTM) -1,736.10 14.95 8.57
Pre-Tax Margin - 5 Yr. Avg. -- 14.74 11.17
Net Profit Margin (TTM) -1,736.10 11.22 4.88
Net Profit Margin - 5 Yr. Avg. -- 11.08 7.47
Effective Tax Rate (TTM) -- 23.21 23.11
Effective Tax Rate - 5 Yr. Avg. -- 23.44 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 953,213,828 864,680,848
Net Income/Employee (TTM) -- 112,151,383 101,718,394
Receivable Turnover (TTM) 6.48 5.60 5.76
Inventory Turnover (TTM) -- 2.58 3.34
Asset Turnover (TTM) 0.05 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -85.70 11.42 11.00
Return on Assets - 5 Yr. Avg. -- 13.00 12.43
Return on Investment (TTM) -193.34 14.86 14.46
Return on Investment - 5 Yr. Avg. -- 17.00 16.28
Return on Equity (TTM) -241.44 16.28 16.05
Return on Equity - 5 Yr. Avg. -- 18.03 17.51
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 43.96 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for EyeGate Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 38.43%
# of Holders: 19
Total Shares Held: 6,611,033
3 Mo. Net Change: -180,845
# New Positions: 5
# Closed Positions: 3
# Increased Positions: 8
# Reduced Positions: 5
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.